Skip to content

Strength Training in Fibromyalgia on Balance, Neuromuscular Performance and Symptoms

Does Strength Training in Fibromyalgia Affect Balance, Neuromuscular Performance and Symptoms? A 12 Week of a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05646641
Enrollment
57
Registered
2022-12-12
Start date
2024-10-05
Completion date
2025-08-07
Last updated
2025-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Brief summary

The purpose of this study is verify the effects of a 8 weeks strength training, on balance, neuromuscular performance and symptomatology of fibromyalgia.

Detailed description

Thirty participants will be recruited. Volunteers will be randomly assigned to the control group or experimental group. Before the training period, symptoms, balance and neuromuscular performance will be assessed. Participants in the experimental group will perform strength training twice a week (50 min each) for eight weeks. Then, four weeks of detraining will be completed.

Interventions

The protocol consists of 8 weeks of training, consisting of 16 sessions of 50 minutes, twice a week on alternate days.

Sponsors

Universidade Federal de Pernambuco
CollaboratorOTHER
University of Beira Interior
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* medical diagnosis of fibromyalgia according to the American College of Rheumatology criteria * at least 18 years old

Exclusion criteria

* severe comorbidity or any other type of condition that negatively influences participation in the training program * cognitive disorders * heart problems * surgeries or fractures in the last 6 months * regular practice of physical exercises in the least 3 months before program.

Design outcomes

Primary

MeasureTime frameDescription
BalanceChange from Baseline balance at week 9Force plate
Neuromuscular performanceChange from Baseline neuromuscular performance at week 9Optical measurement system consisting of two transmitting and receiving cells to assess vertical jump and medicine ball to assess strength of the upper limbs.

Secondary

MeasureTime frameDescription
Anxietybaseline and everyday until the week 12Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose.
Quality of sleepbaseline and everyday until the week 12Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose.
Fibromyalgia impact questionnaireBaseline, week 9, week 12Questionnaire to ccess information on the functional capacity and health status of individuals with fibromyalgia. Composed of 20 questions. , the values vary from 0 to 100, in which the higher the value, the greater the impact of fibromyalgia.
Mood statebaseline and everyday until the week 12Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose.
Fatiguebaseline and everyday until the week 12Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose.
Pain intensitybaseline and everyday until the week 12Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026